BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24159154)

  • 41. [Inhibition of cephalosporinase of enterobacteria by ceftriaxone].
    Péchinot A; Duez JM; Nordmann P; Kazmierczak A; Labia R
    Pathol Biol (Paris); 1986 May; 34(5):399-403. PubMed ID: 3534712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
    Bennett JW; Mende K; Herrera ML; Yu X; Lewis JS; Wickes BL; Jorgensen JH; Murray CK
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):445-8. PubMed ID: 20226336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occurrence & detection of AmpC beta-lactamases at a referral hospital in Karnataka.
    Ratna AK; Menon I; Kapur I; Kulkarni R
    Indian J Med Res; 2003 Jul; 118():29-32. PubMed ID: 14748463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
    Dierikx CM; van Duijkeren E; Schoormans AH; van Essen-Zandbergen A; Veldman K; Kant A; Huijsdens XW; van der Zwaluw K; Wagenaar JA; Mevius DJ
    J Antimicrob Chemother; 2012 Jun; 67(6):1368-74. PubMed ID: 22382469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India.
    Datta P; Thakur A; Mishra B; Gupta V
    Jpn J Infect Dis; 2004 Aug; 57(4):146-9. PubMed ID: 15329445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed.
    Khan AU; Nordmann P
    Scand J Infect Dis; 2012 Jul; 44(7):531-5. PubMed ID: 22497308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime.
    Heusser MF; Patterson JE; Kuritza AP; Edberg SC; Baltimore RS
    Pediatr Infect Dis J; 1990 Jul; 9(7):509-12. PubMed ID: 2371083
    [No Abstract]   [Full Text] [Related]  

  • 48. Multiresistant Enterobacteriaceae: new threat of an old problem.
    Pitout JD
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain.
    Ruiz-Garbajosa P; Curiao T; Tato M; Gijón D; Pintado V; Valverde A; Baquero F; Morosini MI; Coque TM; Cantón R
    J Antimicrob Chemother; 2013 Nov; 68(11):2487-92. PubMed ID: 23788480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Extended-spectrum beta-lactamase producing-enterobacteriaceae].
    Mariani-Kurkdjian P; Doit C; Bingen E
    Arch Pediatr; 2012 Nov; 19 Suppl 3():S93-6. PubMed ID: 23178141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies for identification of carbapenemase-producing Enterobacteriaceae.
    Nordmann P; Poirel L
    J Antimicrob Chemother; 2013 Mar; 68(3):487-9. PubMed ID: 23104494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fecal carriage of third-generation cephalosporins-resistant Enterobacteriaceae in asymptomatic young adults: evolution between 1999 and 2009].
    Janvier F; Mérens A; Delaune D; Soler C; Cavallo JD
    Pathol Biol (Paris); 2011 Apr; 59(2):97-101. PubMed ID: 20828938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden.
    Ostholm-Balkhed A; Tärnberg M; Nilsson M; Johansson AV; Hanberger H; Monstein HJ; Nilsson LE
    Scand J Infect Dis; 2010 Dec; 42(11-12):831-8. PubMed ID: 20608768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Extended-spectrum beta-lactamases in enterobacteria other than Escherichia coli and Klebsiella].
    Seral García C; Pardos de la Gándara M; Castillo García FJ
    Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():12-8. PubMed ID: 20172418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmid-Encoded AmpC (pAmpC) in Enterobacteriaceae: epidemiology of microorganisms and resistance markers.
    Cejas D; Fernández Canigia L; Quinteros M; Giovanakis M; Vay C; Lascialandare S; Mutti D; Pagniez G; Almuzara M; Gutkind G; Radice M
    Rev Argent Microbiol; 2012; 44(3):182-6. PubMed ID: 23102467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended-spectrum beta-lactamase-producing Enterobacteriaceae at Middlemore Hospital.
    Briggs S; Ussher J; Taylor S
    N Z Med J; 2005 Jul; 118(1218):U1563. PubMed ID: 16027752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbapenemases in Enterobacteriaceae: the magnitude of a worldwide concern.
    Rolain JM; Cornaglia G
    Clin Microbiol Infect; 2014 Sep; 20(9):819-20. PubMed ID: 24962130
    [No Abstract]   [Full Text] [Related]  

  • 59. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
    Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
    J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.